Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGPhase 4INTERVENTIONAL

Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The study team will examine the effects of FDA approved stimulant and non-stimulant medications for ADHD, among youth with ADHD and with and without Oppositional Defiant Disorder (ODD) or Conduct Disorder (CD), on reward systems of the brain using fMRI.

Who May Be Eligible (Plain English)

Who May Qualify: - Pre-pubertal (e.g. Tanner stage 1 or 2) - Age 7-12 inclusive - Signed consent/assent - Parent communicates sufficiently in English to provide willing to sign a consent form and complete assessment instruments; - ADHD as determined by computerized DISC (C-DISC) parent interview - ADHD-Rating Scale-5 total score (interview with parent ) - SNAP ADHD total score (teacher) of 1.5 SD \> age/sex norms - CD or severe ODD: CD or ODD + 2 symptoms of CD on C-DISC - SNAP ODD/CD subscale (parent and teacher) 1.5 SD \> age/sex norms Who Should NOT Join This Trial: - Major neurological/medical illness - History of head injury - Fetal exposure to alcohol/drugs - Diagnosis of major psychiatric disorder (e.g., schizophrenia, bipolar disorder, major depression, generalized anxiety, social phobia, Tourette's Disorder, PTSD, autism spectrum disorder) - Current suicidal ideation or past history of suicide attempt - Wechsler Abbreviated Scale of Intelligence (WASI)75 score \<75 - Prior or current treatment with stimulants (prior or current treatment with non-stimulants is permitted, but participants must be off medication for 2 weeks at baseline) - Current or past alcohol/drug use (DISC interview; urine toxicology) - Psychological or medical condition which precludes being in the scanner (e.g., claustrophobia, morbid obesity) - Metal in the body that cannot be removed (e.g., braces, metal plate) - Visual disturbances that may impair task performance - Precocious puberty (e.g. Tanner stage \>2) or pregnancy Notes: - History of SUD in a 1st degree relative is permitted, and is expected in \~1/2 of the subjects - Ongoing psychosocial treatment is allowed but should not be initiated during the study Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Pre-pubertal (e.g. Tanner stage 1 or 2) * Age 7-12 inclusive * Signed consent/assent * Parent communicates sufficiently in English to provide informed consent and complete assessment instruments; * ADHD as determined by computerized DISC (C-DISC) parent interview * ADHD-Rating Scale-5 total score (interview with parent ) * SNAP ADHD total score (teacher) of 1.5 SD \> age/sex norms * CD or severe ODD: CD or ODD + 2 symptoms of CD on C-DISC * SNAP ODD/CD subscale (parent and teacher) 1.5 SD \> age/sex norms Exclusion Criteria: * Major neurological/medical illness * History of head injury * Fetal exposure to alcohol/drugs * Diagnosis of major psychiatric disorder (e.g., schizophrenia, bipolar disorder, major depression, generalized anxiety, social phobia, Tourette's Disorder, PTSD, autism spectrum disorder) * Current suicidal ideation or past history of suicide attempt * Wechsler Abbreviated Scale of Intelligence (WASI)75 score \<75 * Prior or current treatment with stimulants (prior or current treatment with non-stimulants is permitted, but participants must be off medication for 2 weeks at baseline) * Current or past alcohol/drug use (DISC interview; urine toxicology) * Psychological or medical condition which precludes being in the scanner (e.g., claustrophobia, morbid obesity) * Metal in the body that cannot be removed (e.g., braces, metal plate) * Visual disturbances that may impair task performance * Precocious puberty (e.g. Tanner stage \>2) or pregnancy Notes: * History of SUD in a 1st degree relative is permitted, and is expected in \~1/2 of the subjects * Ongoing psychosocial treatment is allowed but should not be initiated during the study

Treatments Being Tested

DRUG

Methylphenidate

stimulant medication

DRUG

Atomoxetine

non-stimulant medication

Locations (1)

Icahn School of Medicine at Mount Sinai
New York, New York, United States